title: Safety of cosmetic dermatologic procedures during pregnancy.
abstract: BACKGROUND
  Safety of cosmetic procedures in pregnant women has not been extensively studied. Maternal and fetal health risks are important to consider in any procedure performed. With the increasing popularity of cosmetic procedures, dermatologic surgeons will be faced with scenarios necessitating knowledge regarding the safety of such procedures during pregnancy. Furthermore, dermatologic surgeons may inadvertently perform cosmetic procedures during the first trimester, before the patient is aware of the pregnancy.
  
  
  OBJECTIVE
  To investigate the safety of cosmetic procedures during pregnancy and the postpartum period.
  
  
  METHODS
  A literature search of PubMed and Google Scholar was conducted of all English-language articles published from 1960 through 2012.
  
  
  RESULTS
  Definitive recommendations on the safety of procedures such as chemical peels, injectables, fillers, and most laser therapies during pregnancy cannot be made. The safety of onabotulinum toxin usage is well documented in the neurology literature, although isolated events of miscarriage have been reported with high doses of toxin in women with a previous history of miscarriage. Carbon dioxide laser therapy for genital condylomas has considerable evidence supporting its safety during pregnancy.
  
  
  CONCLUSIONS
  There is a lack of controlled trials addressing the safety of cosmetic procedures during pregnancy and postpartum periods. It is advisable to delay elective cosmetic procedures until after the baby is born.
authors.affiliation: Department of Dermatology, Brown University, Providence, Rhode Island; Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, Rhode Island.
authors.forename: Kachiu C
authors.initials: KC
authors.lastname: Lee
authors.forename: Kaveri
authors.initials: K
authors.lastname: Korgavkar
authors.forename: Raymond G
authors.initials: RG
authors.lastname: Dufresne
authors.forename: H William
authors.initials: HW
authors.lastname: Higgins
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001777:Blood Coagulation / Q000502:physiology; D003357:Cosmetic Techniques / Q000009:adverse effects; D003879:Dermatologic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D062109:Dermatologic Surgical Procedures / Q000009:adverse effects; D017558:Elective Surgical Procedures; D004564:Electrocoagulation; D005260:Female; D006391:Hemangioma / Q000628:therapy; D006801:Humans; D007774:Lactation; D008895:Milk, Human / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D061214:Patient Safety; D011247:Pregnancy / Q000502:physiology
chemical_list: D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D018377:Neurotransmitter Agents